Identification of an organic anion transport system in the human colon carcinoma cell line HT29 clone 19A

Pflugers Archiv European Journal of Physiology

Volumn 441, Issue 4, 2001, Pages 529-537

  Abrahamse, S L ^a,b,c   Rechkemmer, G ^b,c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b IPF PHARMACEUTICALS GMBH   (Germany)

^c FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

Author keywords

Epithelium; Fluo 3; Intestine; Multidrug resistance; Sulfinpyrazone

Indexed keywords

ANION; CYCLOSPORIN A; DYE; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; PROBENECID; SULFINPYRAZONE; VERAPAMIL; VERLUKAST;

ANION TRANSPORT; APICAL MEMBRANE; ARTICLE; CANCER CELL CULTURE; COLON CARCINOMA; COLON MUCOSA; CONTROLLED STUDY; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOSINE TRIPHOSPHATE; ANILINE COMPOUNDS; ANIONS; BENZOFURANS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; ELECTRIC IMPEDANCE; FLUORESCENT DYES; HT29 CELLS; HUMANS; IMIDAZOLES; MEMBRANE POTENTIALS; MICROSCOPY, FLUORESCENCE; P-GLYCOPROTEIN; PROBENECID; XANTHENES;

EID: 0035141105     PISSN: 00316768     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004240000437     Document Type: Article

References (47)

1. Drug exsorption from blood into the gastrointestinal tract
2. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate
3. Flow cytometric measurement of calcium influx in murine T cell hybrids using Fluo-3 and an organic-anion transport inhibitor
4. P-glycoproteins and multidrug resistance
5. P-glycoprotein multidrug resistance and cancer
6. How to probe clinical tumour samples for P-glycoprotein and multidrug resistance-associated protein
7. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP
8. 2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2
9. Secretion of sparfloxacin from the human intestinal Caco-2 cell line is altered by P-glycoprotein inhibitors
10. 2+ with Fura-2
11. Role of P-glycoprotein as a secretory mechanism in quinidine absorption from rat small intestine
12. Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells
13. The P-glycoprotein multidrug transporter
14. Pharmacology of drugs that alter multidrug resistance in cancer
15. Calcein is excreted from the intestinal mucosal cell membrane by the active transport system
16. The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance
17. Fluorescent cellular indicators are extruded by the multidrug resistance protein
18. Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption
19. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein
20. Organic cation transporters in intestine, kidney, liver, and brain
21. Flow cytometric functional analysis of multidrug resistance by fluo-3: A comparison with rhodamine-123
22. Conjugate export pumps of the multidrug resistance protein (MRP) family: Localization, substrate specificity, and MRP2-mediated drug resistance
23. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane
24. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines
25. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells
26. The biology of the P-glycoproteins
27. Biology of the multidrug resistance-associated protein, MRP
28. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine
29. Fluorescence imaging study of organic anion transport from renal proximal tubule cell to lumen
30. Role of multidrug resistance protein (MRP) in glutathione S-conjugate transport in mammalian cells
31. Molecular aspects of hepatobiliary transport
32. Mechanisms mediating renal secretion of organic anions and cations
33. Blood glutathione concentrations in a large-scale human study
34. The secretory intestinal transport of some beta-lactam antibiotics and anionic compounds: A mechanism contributing to poor oral absorption
35. Involvement of intestinal P-glycoprotein in the restricted absorption of methylprednisolone from rat small intestine
36. Absence of the mdrla P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone digoxin and cyclosporin A
37. Contribution of the murine mdrla P-glycoprotein to hepatobiliary and intestinal elimination of cationic drugs as measured in mice with an mdrla gene disruption
38. Demonstration of organic anion transport in T-lymphocytes. L-Lactate and Fluo-3 are target molecules
39. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
40. Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier
41. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissue
42. Fluorescent probes of cell signaling
43. Carrier-mediated intestinal transport of drugs
44. The pharmacological role of P-glycoprotein in the intestinal epithelium
45. Acceleration of MRP-associated efflux of rhodamine 123 by genistein and related compounds
46. Active secretion and enterocytic drug metabolism barriers to drug absorption
47. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds